PH III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Previously Untreated Multiple Myeloma (ELO 1 Substudy)

Local Institution, Athens

Local Institution, Genova

Medical University Of South Carolina Hollings Cancer Center, Charleston

Memorial Cancer Institute, Hollywood

Baptist Cancer Center, Memphis

Ohio State University Medical Center, Columbus

Franciscan St. Francis Health, Indianapolis

Illinois Cancercare, Pc, Peoria

Crescent City Research Consortium, LLC, Marrero

Northern Utah Associates, Ogden

Pacific Hematology Oncology Associates, San Francisco

Local Institution, Rome

Local Institution, Chorzów

Local Institution, Lublin